News and Updates

Congress is Making Quiet Progress on Drug Costs

The Commonwealth Fund published a To the Point blog post detailing the incremental steps that Congress has taken on policies that would lower drug costs for patients.

Hatch Amendment Could Delay Generic Drug Competition and Increase Drug Prices

If it passes in Congress, the unfortunately named Hatch-Waxman Integrity Act of 2018 would ultimately delay generic drug competition and increase drug prices.

California Health Care Foundation Interviews Waxman Strategies Chairman Henry Waxman on the Future of Health Policy

California Health Care Foundation (CHCF) interviews  Waxman Strategies Chairman Henry Waxman on the changing political landscape of health care reform.

Former Congress Henry Waxman Speaks About Drug Prices and the Affordable Care Act at Spotlight Health in Aspen, CO

Former Congressman Henry Waxman (D-Calif.) and chairman of Waxman Strategies participated last weekend in the Aspen Institute’s annual Spotlight Health event to talk about rising prescription drug prices, as well as, reminisce on the Affordable Care Act (ACA).

Analyzing the US Food and Drug Administration’s Plans to Increase Competition in Response to High Drug Prices

Prescription drug prices have reached an all-time high. FDA Commissioner Gottlieb has taken on the issue indirectly, and announced several actions by the FDA intended to increase generic drug competition and transparency.

Former Congressman Henry Waxman’s Op-Ed in the Washington Post

Democrats shouldn’t impose litmus tests on health care.

Bipartisan Deal Includes Important Step to Control Medicaid Drug Prices, But More Efforts Are Needed

Today, the Commonwealth Fund published a blog post on the Bipartisan Budget Act of 2018, which will have an impact on Medicaid drug prices.

Trump Budget’s Prescription Drug Proposals Could Lower Patients’ Costs and Federal Spending; Some Could Lower Drug Prices

The Trump administration laid out a package of proposals to lower drug costs in the president’s budget for fiscal year 2019.

Bipartisan Legislation, the CREATES Act, Tackles One Problem Driving High Drug Prices

The CREATES Act tackles one of the numerous problems driving high drug prices that Waxman Strategies described in their recent report.

 

Mighty Earth Report Reveals Major Chocolate Companies Sourcing Chocolate Linked to Deforestation

Mighty Earth’s investigation finds that cocoa used in the chocolate produced by Mars, Nestle, Hershey’s and Godiva was grown illegally in protected areas.